The estimated Net Worth of Emily M. Leproust is at least $89.6 Milión dollars as of 6 September 2024. Ms. Leproust owns over 2,340 units of Twist Bioscience Corp stock worth over $22,058,143 and over the last 6 years she sold TWST stock worth over $59,412,233. In addition, she makes $8,126,160 as Chairman of the Board, President a Chief Executive Officer at Twist Bioscience Corp.
Emily has made over 45 trades of the Twist Bioscience Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 2,340 units of TWST stock worth $91,634 on 6 September 2024.
The largest trade she's ever made was selling 100,000 units of Twist Bioscience Corp stock on 4 September 2020 worth over $6,298,000. On average, Emily trades about 7,289 units every 16 days since 2018. As of 6 September 2024 she still owns at least 497,253 units of Twist Bioscience Corp stock.
You can see the complete history of Ms. Leproust stock trades at the bottom of the page.
Emily M. Leproust Ph.D. serves as Chairman of the Board, President, Chief Executive Officer of the Company. She was also appointed as Chair of our board of directors effective as of October 2018. Prior to co-founding Twist, Dr. Leproust served in various positions at Agilent most recently as its Director, Applications and Chemistry R&D from February 2009 to April 2013. Dr. Leproust holds a M.Sc. in Industrial Chemistry from the Lyon School of Industrial Chemistry and a Ph.D. in Organic Chemistry from the University of Houston.
As the Chairman of the Board, President a Chief Executive Officer of Twist Bioscience Corp, the total compensation of Emily Leproust at Twist Bioscience Corp is $8,126,160. There are no executives at Twist Bioscience Corp getting paid more.
Emily Leproust is 46, she's been the Chairman of the Board, President a Chief Executive Officer of Twist Bioscience Corp since 2018. There are 22 older and 1 younger executives at Twist Bioscience Corp. The oldest executive at Twist Bioscience Corp is Dr. William Charles Banyai Ph.D., 66, who is the Sr. VP of Advanced Devel., GM of Data Storage & Director.
Emily's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell a Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: